Barbara K Finck - Net Worth and Insider Trading
Barbara K Finck Net Worth
The estimated net worth of Barbara K Finck is at least $42,370 dollars as of 2024-09-20. Barbara K Finck is the Chief Medical Officer of Coherus BioSciences Inc and owns about 37,043 shares of Coherus BioSciences Inc (CHRS) stock worth over $41,859. Barbara K Finck is also the Director of Comera Life Sciences Holdings Inc and owns about 23,033 shares of Comera Life Sciences Holdings Inc (CMRA) stock worth over $511. Details can be seen in Barbara K Finck's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Barbara K Finck has not made any transactions after 2023-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Barbara K Finck
Barbara K Finck Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barbara K Finck owns 3 companies in total, including Coherus BioSciences Inc (CHRS) , Forte Biosciences Inc (FBRX) , and Comera Life Sciences Holdings Inc (CMRA) .
Click here to see the complete history of Barbara K Finck’s form 4 insider trades.
Insider Ownership Summary of Barbara K Finck
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CHRS | Coherus BioSciences Inc | 2018-09-10 | Chief Medical Officer |
| FBRX | Forte Biosciences Inc | 2022-03-16 | director |
| CMRA | Comera Life Sciences Holdings Inc | 2023-01-04 | director |
Barbara K Finck Latest Holdings Summary
Barbara K Finck currently owns a total of 2 stocks. Among these stocks, Barbara K Finck owns 37,043 shares of Coherus BioSciences Inc (CHRS) as of September 10, 2018, with a value of $41,859 and a weighting of 98.79%. Barbara K Finck also owns 23,033 shares of Comera Life Sciences Holdings Inc (CMRA) as of January 4, 2023, with a value of $511 and a weighting of 1.21%.
Latest Holdings of Barbara K Finck
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CHRS | Coherus BioSciences Inc | 2018-09-10 | 37,043 | 1.13 | 41,859 |
| CMRA | Comera Life Sciences Holdings Inc | 2023-01-04 | 23,033 | 0.02 | 511 |
Holding Weightings of Barbara K Finck
Barbara K Finck Form 4 Trading Tracker
According to the SEC Form 4 filings, Barbara K Finck has made a total of 0 transactions in Coherus BioSciences Inc (CHRS) over the past 5 years. The most-recent trade in Coherus BioSciences Inc is the sale of 1,760 shares on September 10, 2018, which brought Barbara K Finck around $32,701.
According to the SEC Form 4 filings, Barbara K Finck has made a total of 1 transactions in Comera Life Sciences Holdings Inc (CMRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Comera Life Sciences Holdings Inc is the acquisition of 6,756 shares on January 4, 2023, which cost Barbara K Finck around $8,310.
Insider Trading History of Barbara K Finck
- 1
Barbara K Finck Trading Performance
GuruFocus tracks the stock performance after each of Barbara K Finck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barbara K Finck is -31.78%. GuruFocus also compares Barbara K Finck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barbara K Finck within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barbara K Finck's insider trading performs compared to the benchmark.
Performance of Barbara K Finck
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.33 | | | | | |
| Relative Return to S&P 500(%) | -5.03 | | | | | |
Barbara K Finck Ownership Network
Barbara K Finck Owned Company Details
What does Coherus BioSciences Inc do?
Who are the key executives at Coherus BioSciences Inc?
Barbara K Finck is the Chief Medical Officer of Coherus BioSciences Inc. Other key executives at Coherus BioSciences Inc include director & President and CEO Dennis M Lanfear , Chief Financial Officer Mcdavid Stilwell , and See Remarks Bryan J Mcmichael .
Coherus BioSciences Inc (CHRS) Insider Trades Summary
Over the past 18 months, Barbara K Finck made no insider transaction in Coherus BioSciences Inc (CHRS). Other recent insider transactions involving Coherus BioSciences Inc (CHRS) include a net sale of 223,100 shares made by Dennis M Lanfear ,
In summary, during the past 3 months, insiders sold 0 shares of Coherus BioSciences Inc (CHRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 223,100 shares of Coherus BioSciences Inc (CHRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 223,100 shares.
Coherus BioSciences Inc (CHRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Coherus BioSciences Inc Insider Transactions
Barbara K Finck Mailing Address
Above is the net worth, insider trading, and ownership report for Barbara K Finck. You might contact Barbara K Finck via mailing address: C/o Protine Design Lab, 3858 Jackson St, San Francisco Ca 94118.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
